Why Theranos’s blood-testing claims were always too good to be true

Last week, the tech CEO Elizabeth Holmes – once described as ‘the next Steve Jobs’ – was convicted of fraud, and could face decades in prison. Her now collapsed company, Theranos, promised to revolutionise medicine with a machine that could run hundreds of health tests on just a pinprick of blood. Those claims have since been exposed as false – but could they ever have been true? Madeleine Finlay speaks to the Guardian’s wealth correspondent, Rupert Neate, about Silicon Valley’s trial of the century, and pathologist Dr Benjamin Mazer about why Theranos’s vision seemed impossible from the start. Help support our independent journalism at theguardian.com/sciencepod
13 Jan 2022 English United Kingdom Science · Nature

Other recent episodes

Why is Nasa looking into UFOs and what has it found so far?

Last week, Nasa held the first public meeting of a panel established to investigate sightings of UFOs. It came just before a whistleblower former intelligence official told the Debrief that the US government had ‘intact and partially intact’ craft of non-human origin. Ian Sample talks to Prof David Spergel, the…
8 Jun 17 min

Why are food allergies on the rise and is a cure on the horizon?

Food allergies appear to be increasing globally, but as scientific understanding improves, some experts believe we may one day be able to eliminate them altogether. Ian Sample speaks to Dr Kari Nadeau, an allergy specialist at Harvard School of Public Health and author of the book The End of Food…
1 Jun 16 min

Japanese knotweed: why is it so damaging and can it be stopped?

Since it was introduced to the UK in 1850, Japanese knotweed has gone from novel ornamental plant to rampant invasive species. Madeleine Finlay speaks to journalist Samanth Subramanian about the huge costs associated with finding it on a property, and Dr Sophie Hocking explains what the plant, and our attempts…
25 May 18 min